Orbimed Advisors LLC — 13F Holdings

2026 Q3  ·  162 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, ORBIMED ADVISORS LLC maintained a portfolio of 162 distinct positions. The most significant new addition was ADARX PHARMACEUTICALS INC, now representing 8.78% of the total fund value. They heavily accumulated shares in UNITEDHEALTH GROUP INC, increasing the position by 2090.0%. The fund also reduced its exposure to ASTRAZENECA PLC by 58.6%.
Position History hover any row below to update
Loading…
ORBIMED ADVISORS LLC New York, NY Hedge Fund / Asset Manager AUM $5,442M
PCA Score Concentration Risk
Risk ENB
Total Positions
162
Quarter
2026 Q3
Top Holding
EWTX (11.5%)
Top 10 Concentration
48.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 162

ORBIMED ADVISORS LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
EWTX
EDGEWISE THERAP...
Healthcare 11.46% 11.68% #1
Prev: #1
7.0
—
no change no change
P
S
15,518,492 $630,050,775 2021 Q1 13F Filing 2026-09-30 2026-11-16
ADRX
ADARX PHARMACEU...
Healthcare 8.78% — #2
Prev: #—
8.5
—
24,205,789 —
NEW
24,205,789 $482,663,433 2026 Q3 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 5.65% 6.37% #3 1
Prev: #2
4.3
—
no change no change
P
S
6,776,632 $310,640,811 2023 Q1 13F Filing 2026-09-30 2026-11-16
LLY
ELI LILLY & CO
Healthcare 5.43% 5.73% #4 1
Prev: #3
3.7
—
no change no change
P
S
257,900 $298,410,932 2001 Q2 13F Filing 2026-09-30 2026-11-16
BRVE
BRAVEHEART BIO ...
Healthcare 4.47% — #5
Prev: #—
5.8
—
12,175,159 —
NEW
12,175,159 $245,938,212 2026 Q3 13F Filing 2026-09-30 2026-11-16
SVA
SINOVAC BIOTECH...
Unknown 3.56% 3.42% #6 1
Prev: #5
2.4
—
no change no change
P
S
2,718,735 $195,500,000 2011 Q4 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 3.28% 3.51% #7 3
Prev: #4
1.8
—
-353,883 -10.3%
P
S
3,074,853 $180,247,883 2024 Q3 13F Filing 2026-09-30 2026-11-16
MRK
MERCK & CO INC
Healthcare 2.50% 1.58% #8 5
Prev: #13
3.5
—
282,700 42.6%
P
S
946,100 $137,477,791 2003 Q3 13F Filing 2026-09-30 2026-11-16
GH
GUARDANT HEALTH...
Healthcare 1.89% 1.62% #9 2
Prev: #11
1.3
—
400 0.1%
P
S
584,100 $104,180,076 2018 Q4 13F Filing 2026-09-30 2026-11-16
AVBP
ARRIVENT BIOPHA...
Healthcare 1.67% 1.95% #10
Prev: #10
1.7
—
no change no change
P
S
3,027,328 $91,667,492 2024 Q1 13F Filing 2026-09-30 2026-11-16
CRVS
CORVUS PHARMACE...
Healthcare 1.50% 1.98% #11 2
Prev: #9
1.6
—
no change no change
P
S
7,165,006 $82,540,869 2016 Q1 13F Filing 2026-09-30 2026-11-16
NTRA
NATERA INC
Healthcare 1.50% 1.32% #12 8
Prev: #20
0.6
—
-62,300 -23.8%
P
S
199,700 $82,538,007 2015 Q3 13F Filing 2026-09-30 2026-11-16
ARQT
ARCUTIS BIOTHER...
Healthcare 1.50% 0.99% #13 19
Prev: #32
3.6
—
1,080,100 52.9%
P
S
3,122,100 $82,517,103 2020 Q1 13F Filing 2026-09-30 2026-11-16
TMO
THERMO FISHER S...
Healthcare 1.48% 0.84% #14 24
Prev: #38
3.1
—
29,700 32.7%
P
S
120,400 $81,276,020 2006 Q4 13F Filing 2026-09-30 2026-11-16
UNH
UNITEDHEALTH GR...
Healthcare 1.46% 1.24% #15 7
Prev: #22
3.1
—
57,900 35.9%
P
S
219,000 $80,390,520 2009 Q2 13F Filing 2026-09-30 2026-11-16
ASND
ASCENDIS PHARMA...
Healthcare 1.43% 1.21% #16 8
Prev: #24
3.1
—
100,744 41.2%
P
S
345,200 $78,646,916 2015 Q1 13F Filing 2026-09-30 2026-11-16
ETRA
ELECTRA THERAPE...
Healthcare 1.41% — #17
Prev: #—
4.1
—
6,885,170 —
NEW
6,885,170 $77,458,163 2026 Q3 13F Filing 2026-09-30 2026-11-16
ARGX
ARGENX SE
Healthcare 1.31% 1.60% #18 6
Prev: #12
1.0
—
-17,700 -19.1%
P
S
75,180 $72,090,854 2017 Q2 13F Filing 2026-09-30 2026-11-16
EW
EDWARDS LIFESCI...
Healthcare 1.31% 1.40% #19 3
Prev: #16
1.5
—
no change no change
P
S
834,900 $72,068,568 2011 Q1 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
Healthcare 1.29% 0.27% #20 58
Prev: #78
3.5
—
947,425 374.5%
P
S
1,200,425 $70,681,024 2021 Q1 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 1.26% — #21
Prev: #—
4.0
—
2,777,621 —
NEW
2,777,621 $69,301,644 2024 Q4 13F Filing 2026-09-30 2026-11-16
ABBV
ABBVIE INC
Healthcare 1.24% — #22
Prev: #—
4.0
—
259,600 —
NEW
259,600 $67,908,764 2013 Q1 13F Filing 2026-09-30 2026-11-16
CAI
CARIS LIFE SCIE...
Healthcare 1.22% 0.93% #23 13
Prev: #36
0.5
—
-613,900 -21.9%
P
S
2,192,911 $67,168,864 2025 Q2 13F Filing 2026-09-30 2026-11-16
ODTX
ODYSSEY THERAPE...
Healthcare 1.21% 1.04% #24 6
Prev: #30
1.5
—
no change no change
P
S
3,001,198 $66,686,620 2026 Q2 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 1.17% 1.21% #25 1
Prev: #26
2.5
—
322,400 19.2%
P
S
2,003,700 $64,158,474 2020 Q4 13F Filing 2026-09-30 2026-11-16
AZNCF
ASTRAZENECA PLC
Unknown 1.12% 3.17% #26 20
Prev: #6
0.4
—
-536,400 -58.6%
P
S
379,300 $61,782,783 2026 Q1 13F Filing 2026-09-30 2026-11-16
CDNA
CAREDX INC
Healthcare 1.11% — #27
Prev: #—
3.9
—
934,800 —
NEW
934,800 $60,762,000 2019 Q1 13F Filing 2026-09-30 2026-11-16
PRAX
PRAXIS PRECISIO...
Healthcare 1.06% 1.43% #28 13
Prev: #15
0.9
—
-29,700 -12.9%
P
S
200,400 $58,362,492 2024 Q1 13F Filing 2026-09-30 2026-11-16
ABT
ABBOTT LABORATO...
Healthcare 1.04% — #29
Prev: #—
3.9
—
579,000 —
NEW
579,000 $57,222,570 2007 Q2 13F Filing 2026-09-30 2026-11-16
PRLD
PRELUDE THERAPE...
Healthcare 0.98% 1.36% #30 13
Prev: #17
1.4
—
no change no change
P
S
13,724,571 $53,663,073 2020 Q3 13F Filing 2026-09-30 2026-11-16
BLSM
BLOSSOMHILL THE...
Healthcare 0.92% — #31
Prev: #—
3.9
—
2,714,279 —
NEW
2,714,279 $50,594,161 2026 Q3 13F Filing 2026-09-30 2026-11-16
HUM
HUMANA INC
Healthcare 0.89% 1.21% #32 7
Prev: #25
0.4
—
-36,300 -22.1%
P
S
127,800 $48,764,646 2010 Q4 13F Filing 2026-09-30 2026-11-16
STTK
SHATTUCK LABS I...
Healthcare 0.78% 0.81% #33 8
Prev: #41
1.3
—
no change no change
P
S
6,306,127 $43,007,786 2025 Q3 13F Filing 2026-09-30 2026-11-16
GPCR
STRUCTURE THERA...
Healthcare 0.76% 2.20% #34 27
Prev: #7
0.3
—
-878,400 -39.8%
P
S
1,331,000 $41,620,370 2024 Q2 13F Filing 2026-09-30 2026-11-16
URGN
UROGEN PHARMA L...
Healthcare 0.73% 0.46% #35 23
Prev: #58
2.8
—
312,300 46.2%
P
S
988,487 $40,162,227 2025 Q2 13F Filing 2026-09-30 2026-11-16
ISRG
INTUITIVE SURGI...
Healthcare 0.72% 1.16% #36 8
Prev: #28
0.3
—
-61,100 -38.7%
P
S
96,800 $39,361,784 2010 Q2 13F Filing 2026-09-30 2026-11-16
RYTM
RHYTHM PHARMACE...
Healthcare 0.71% 0.66% #37 7
Prev: #44
2.8
—
85,100 26.4%
P
S
408,000 $38,847,720 2017 Q4 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
Healthcare 0.66% 1.05% #38 9
Prev: #29
0.3
—
-655,728 -31.1%
P
S
1,454,572 $36,553,394 2024 Q1 13F Filing 2026-09-30 2026-11-16
SPRY
ARS PHARMACEUTI...
Healthcare 0.65% 1.23% #39 16
Prev: #23
1.3
—
no change no change
P
S
8,288,510 $35,723,478 2020 Q4 13F Filing 2026-09-30 2026-11-16
QTTB
Q32 BIO INC
Healthcare 0.62% 0.97% #40 6
Prev: #34
1.2
—
no change no change
P
S
4,127,987 $34,138,452 2024 Q1 13F Filing 2026-09-30 2026-11-16
KRYS
KRYSTAL BIOTECH...
Healthcare 0.59% 0.57% #41 8
Prev: #49
2.2
—
14,500 17.4%
P
S
97,700 $32,491,112 2019 Q1 13F Filing 2026-09-30 2026-11-16
PVLA
PALVELLA THERAP...
Healthcare 0.58% 0.83% #42 3
Prev: #39
0.2
—
-62,500 -21.4%
P
S
229,860 $31,704,590 2026 Q1 13F Filing 2026-09-30 2026-11-16
AXSM
AXSOME THERAPEU...
Healthcare 0.57% 0.53% #43 8
Prev: #51
2.7
—
53,300 45.3%
P
S
170,878 $31,508,194 2021 Q1 13F Filing 2026-09-30 2026-11-16
JAZZ
JAZZ PHARMACEUT...
Healthcare 0.55% — #44
Prev: #—
3.7
—
131,100 —
NEW
131,100 $30,352,272 2013 Q2 13F Filing 2026-09-30 2026-11-16
UPB
UPSTREAM BIO IN...
Healthcare 0.55% 0.73% #45 3
Prev: #42
1.2
—
no change no change
P
S
5,693,589 $30,005,214 2024 Q4 13F Filing 2026-09-30 2026-11-16
WST
WEST PHARMACEUT...
Healthcare 0.54% 0.47% #46 10
Prev: #56
2.2
—
9,580 13.6%
P
S
80,180 $29,727,537 2026 Q2 13F Filing 2026-09-30 2026-11-16
LTGO
LATIGO BIOTHERA...
Healthcare 0.51% — #47
Prev: #—
3.7
—
1,675,316 —
NEW
1,675,316 $27,977,777 2026 Q3 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 0.45% — #48
Prev: #—
3.7
—
314,500 —
NEW
314,500 $25,009,040 2025 Q3 13F Filing 2026-09-30 2026-11-16
SCTX
SCRIBE THERAPEU...
Healthcare 0.45% — #49
Prev: #—
3.7
—
1,348,825 —
NEW
1,348,825 $24,825,124 2026 Q3 13F Filing 2026-09-30 2026-11-16
DXCM
DEXCOM INC
Healthcare 0.44% — #50
Prev: #—
3.7
—
278,000 —
NEW
278,000 $23,988,620 2018 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 162 holdings

Unlock Full ORBIMED ADVISORS LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →